Actavis' Growth 'Underappreciated," Sterne Agee Says AVYCAZ – First In Its Class AVYCAZ, a new antibiotic developed by Actavis has become the first drug in its class to receive approval based on ...

Allergan has won US approval for its fixed-dose combination antibiotic Avycaz in a new indication, becoming the first new drug to treat pneumonia caused by Gram-negative bacterial infections in more ...

Feb 1 (Reuters) - Allergan Plc said on Thursday the U.S. Food and Drug Administration had approved the drugmaker’s antibiotic Avycaz to treat two types of pneumonia caused by drug-resistant ...

Feb 1 (Reuters) - Allergan Plc said on Thursday the U.S. Food and Drug Administration had approved the drugmaker's antibiotic Avycaz to treat two types of pneumonia caused by drug-resistant bacteria.

(HealthDay)—The combination antibiotic Avycaz (ceftazidime-avibactam) has been approved by the U.S. Food and Drug Administration to treat adults with complicated infections of the intra ...

For Actavis, the new approval helps it extend its presence in the field – having bought Durata Therapeutics along with its recently approved antibiotic Dalvance (dalbavancin) in October. Avycaz ...

More importantly, though, the early success of Avycaz "bodes well" for other gram-negative antibiotics that are making their way through the pipeline--"especially the ones that work on bugs for ...

Allergan plc AGN announced that its supplemental new drug application for antibiotic Avycaz (ceftazidime and avibactam; ex-U.S. trade name: Zavicefta), has been accepted for review by the FDA.

Allergan’s superbug antibiotic Avycaz raked in $22.1 million in sales during H1. But it will be slow going for the rest of 2016 because of an issue with its API maker delaying production ...

The FDA has approved a new antibiotic, Avycaz, to treat resistant infections. Above, a laboratory worker looks for strains of E.coli bacteria in vegetable cells placed in a petri dish, in La ...